Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 AUD | -2.60% | +2.74% | +8.70% |
17/04 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
17/04 | Neurotech International Completes AU$10 Million Capital Raise | MT |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- MarketScreener Editorial Features